64
Views
5
CrossRef citations to date
0
Altmetric
Case Report

5% lidocaine medicated plaster double effect in a case of orofacial localized neuropathic pain

, &
Pages 639-643 | Published online: 24 Nov 2014

References

  • TreedeRDJensenTSCampbellJNNeuropathic pain: redefinition and a grading system for clinical and research purposesNeurology200870181630163518003941
  • MickGBaronRFinnerupNBWhat is localized neuropathic pain? A first proposal to characterize and define a widely used termPain Manag201221717724654620
  • AttalNCruccuGBaronREuropean Federation of Neurological SocietiesEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol20101791113e8820402746
  • DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain2007132323725117920770
  • ComerAMLambHMLidocaine patch 5%Drugs2000592245249 discussion 250–25110730547
  • GalerBSRowbothamMCPeranderJFriedmanETopical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment studyPain199980353353810342414
  • MickGCorrea-IllanesGTopical pain management with the 5% lidocaine medicated plaster – a reviewCurr Med Res Opin201228693795122551228
  • CampbellRLParksKWDoddsRNChronic facial pain associated with endodontic therapyOral Surg Oral Med Oral Pathol19906932872902314854
  • OkesonJPOrofacial Pain: Guidelines for Assessment, Diagnosis and Management3rd edChicago, ILQuintessence2006
  • de LeeuwROrofacial Pain: Guidelines for Assessment, Diagnosis, and ManagementHanover Park, ILQuintessence2008
  • RehmSBinderABaronRPost-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness studyCurr Med Res Opin20102671607161920429825
  • LamVYWallaceMSchulteisGEffects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trialJ Pain201112332333020889387
  • CasaleRMattiaCBuilding a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plasterTher Clin Risk Manag20141025926824790451
  • RowbothamMCDaviesPSVerkempinckCGalerBSLidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgiaPain199665139448826488
  • CasaleRDi MatteoMMinellaCEFanelliGAllegriMReduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case seriesJ Pain Res2014735335725018649
  • SessleBJHuJWAmanoNZhongGConvergence of cutaneous, tooth pulp, visceral, neck and muscle afferents onto nociceptive and non-nociceptive neurones in trigeminal subnucleus caudalis (medullary dorsal horn) and its implications for referred painPain19862722192353797017
  • GammaitoniARAlvarezNAGalerBSPharmacokinetics and safety of continuously applied lidocaine patches 5%Am J Health Syst Pharm200259222215222012455305
  • BaronRHansGDickensonAHPeripheral input and its importance for central sensitizationAnn Neurol201374563063624018757
  • ChongMSSmithTEHannaMCase reports – reversal of sensory deficit associated with pain relief after treatment with gabapentinPain200296332933311973006
  • Correa-IllanesGCalderónWRoaRPiñerosJLDoteJMedinaDTreatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plasterLocal Reg Anesth20103778322915873